Last 24.70 INR
Change Today +0.40 / 1.65%
Volume 278.4K
ISL On Other Exchanges
Symbol
Exchange
Natl India
As of 6:06 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

ind-swift laboratories ltd (ISL) Snapshot

Open
24.25
Previous Close
24.30
Day High
25.00
Day Low
23.75
52 Week High
07/3/14 - 57.60
52 Week Low
12/17/14 - 22.05
Market Cap
1.0B
Average Volume 10 Days
63.3K
EPS TTM
-29.11
Shares Outstanding
41.0M
EX-Date
09/20/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IND-SWIFT LABORATORIES LTD (ISL)

Related News

No related news articles were found.

ind-swift laboratories ltd (ISL) Related Businessweek News

No Related Businessweek News Found

ind-swift laboratories ltd (ISL) Details

Ind-Swift Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India and internationally. The company operates through Bulk Drugs & Pharmaceuticals segment. It primarily offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyroidism, analgesic, aromatase inhibitor, nootropic, antihypertensive, antibacterial Quinolone, antidiarrhoeal, alcohol abstinence, antineoplastic, prostatic hyperplasia, and treatment of premature ejaculation; and others in glucocorticoids therapeutic area. The company also provides various products that are under development stage in prostatic hypertrophy, overactive bladder syndrome, and osteoporosis therapeutic areas. In addition, it offers menthol and mint derivatives under the Ind COOL brand. Further, the company provides contract research and manufacturing services, including early phase drug development, process research and development, custom chemical synthesis, contract and API manufacturing, and FTE, as well as analytical and regulatory submission support services. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India.

Founded in 1995

ind-swift laboratories ltd (ISL) Top Compensated Officers

Vice Chairman, Managing Director, Chairman of...
Total Annual Compensation: 18.0M
Joint Managing Director, Whole Time Director ...
Total Annual Compensation: 18.0M
Executive Director
Total Annual Compensation: 4.8M
Compensation as of Fiscal Year 2014.

ind-swift laboratories ltd (ISL) Key Developments

Ind-Swift Laboratories Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Ind-Swift Laboratories Ltd. reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net sales were INR 1,599.619 million, profit from operation before other income, finance costs and exceptional items was INR 121.379 million, loss from ordinary activities before tax of INR 191.248, net loss for the period was INR 187.652 million or INR 4.58 diluted per share as compared to net sales were INR 2,349.678 million, profit from operation before other income, finance costs and exceptional items was INR 222.82 million, loss from ordinary activities before tax of INR 85.869, net loss for the period was INR 85.694 million or INR 2.18 diluted per share for the same period last year. For the nine months, the company reported net sales were INR 3,440.706 million, profit from operation before other income, finance costs and exceptional items was INR 231.948 million, loss from ordinary activities before tax of INR 362.38, net loss for the period was INR 358.803 million or INR 8.76 diluted per share as compared to net sales were INR 4,839.549 million, loss from operation before other income, finance costs and exceptional items was INR 416.028 million, loss from ordinary activities before tax of INR 164.858, net loss for the period was INR 164.683 million or INR 4.19 diluted per share for the same period last year.

Ind-Swift Laboratories Ltd. to Report Q2, 2015 Results on Nov 07, 2014

Ind-Swift Laboratories Ltd. announced that they will report Q2, 2015 results on Nov 07, 2014

Ind-Swift Laboratories Ltd., Board Meeting, Nov 07, 2014

Ind-Swift Laboratories Ltd., Board Meeting, Nov 07, 2014. Agenda: To consider the unaudited financial results for the quarter ended September 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISL:IN 24.70 INR +0.40

ISL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $45.70 USD -0.02
View Industry Companies
 

Industry Analysis

ISL

Industry Average

Valuation ISL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IND-SWIFT LABORATORIES LTD, please visit www.indswiftlabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.